These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 30861263)
1. Secondary sclerosing cholangitis with hemobilia induced by pembrolizumab: Case report and review of published work. Koya Y; Shibata M; Shinohara N; Nebuya S; Oe S; Honma Y; Senju M; Sato N; Harada M Hepatol Res; 2019 Aug; 49(8):950-956. PubMed ID: 30861263 [TBL] [Abstract][Full Text] [Related]
2. Pembrolizumab-induced sclerosing cholangitis in a lung adenocarcinoma patient with a remarkable response to chemotherapy: a case report. Sato K; Hayashi M; Abe K; Fujita M; Takahashi A; Ohira H Clin J Gastroenterol; 2020 Dec; 13(6):1310-1314. PubMed ID: 32643124 [TBL] [Abstract][Full Text] [Related]
3. Delayed immune-related sclerosing cholangitis after discontinuation of pembrolizumab: A case report. Tanaka T; Sakai A; Tsujimae M; Yamada Y; Kobayashi T; Masuda A; Kodama Y World J Gastroenterol; 2022 Jul; 28(28):3732-3738. PubMed ID: 36161046 [TBL] [Abstract][Full Text] [Related]
4. Pembrolizumab-related cholangitis with multiple fatal liver abscesses after endoscopic biliary drainage: a case report and review of the literature. Hori H; Fujita K; Nishio A; Nishijima M; Inaba M; Anami T; Matsui S; Kitamura Y; Matsuoka R; Watanabe A Clin J Gastroenterol; 2022 Apr; 15(2):475-479. PubMed ID: 35072901 [TBL] [Abstract][Full Text] [Related]
5. Massive hemobilia following plastic stent removal in common bile duct cancer associated with primary sclerosing cholangitis (with video). Miyamoto H; Tanaka K; Nakamura F; Ikeda T; Kitamura S; Kimura T; Okamoto K; Sogabe M; Muguruma N; Bando Y; Takayama T Clin J Gastroenterol; 2019 Feb; 12(1):46-51. PubMed ID: 30056613 [TBL] [Abstract][Full Text] [Related]
6. Langerhans cell histiocytosis confined to extrahepatic bile duct causing sclerosing cholangitis in child: a case report. Murakami M; Onishi S; Ohya Y; Kawabata S; Isono K; Sugawara Y; Asato T; Honda Y; Mikami Y; Inomata Y; Hibi T; Ieiri S Surg Case Rep; 2020 Jun; 6(1):137. PubMed ID: 32548778 [TBL] [Abstract][Full Text] [Related]
7. Pembrolizumab-induced secondary sclerosing cholangitis in a non-small cell lung cancer patient. Matsumoto S; Watanabe K; Kobayashi N; Irie K; Yamanaka S; Kaneko T Respirol Case Rep; 2020 Jul; 8(5):e00560. PubMed ID: 32284868 [TBL] [Abstract][Full Text] [Related]
8. IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis? Zen Y; Harada K; Sasaki M; Sato Y; Tsuneyama K; Haratake J; Kurumaya H; Katayanagi K; Masuda S; Niwa H; Morimoto H; Miwa A; Uchiyama A; Portmann BC; Nakanuma Y Am J Surg Pathol; 2004 Sep; 28(9):1193-203. PubMed ID: 15316319 [TBL] [Abstract][Full Text] [Related]
9. Pembrolizumab Induced Sclerosing Cholangitis: Why You Need a Liver Biopsy. Liang I; Chu G; Zielinski R Case Rep Oncol; 2023; 16(1):182-187. PubMed ID: 37013108 [TBL] [Abstract][Full Text] [Related]
10. A case report of immune checkpoint inhibitor-related myositis and cholangitis induced by pembrolizumab. Yamano T; Hamakawa M; Akaike Y; Ishida T Clin Case Rep; 2024 Jul; 12(7):e9153. PubMed ID: 38962456 [TBL] [Abstract][Full Text] [Related]
11. Pembrolizumab-Related Sclerosing Cholangitis in a Patient With High Microsatellite Instability Gastric Cancer: A Case Report. Honma S; Watanabe S; Nakajima S Cureus; 2024 Aug; 16(8):e66425. PubMed ID: 39247024 [TBL] [Abstract][Full Text] [Related]
12. Clinical features, treatment, and outcome of pembrolizumab induced cholangitis. Fang W; Sun W; Fang W; Zhang J; Wang C Naunyn Schmiedebergs Arch Pharmacol; 2024 Oct; 397(10):7905-7912. PubMed ID: 38748225 [TBL] [Abstract][Full Text] [Related]
13. [A contribution to the differential diagnostics of sclerosing cholangitides]. Blaho M; Dítě P; Bojková M; Rydlo M; Kupka T; Svoboda P; Klvaňa P; Martínek A Vnitr Lek; 2017; 63(1):50-55. PubMed ID: 28225291 [TBL] [Abstract][Full Text] [Related]
14. Secondary sclerosing cholangitis in patients with drug-induced liver injury. Gudnason HO; Björnsson HK; Gardarsdottir M; Thorisson HM; Olafsson S; Bergmann OM; Björnsson ES Dig Liver Dis; 2015 Jun; 47(6):502-7. PubMed ID: 25840876 [TBL] [Abstract][Full Text] [Related]
15. Extrahepatic biliary stenoses after hepatic arterial infusion (HAI) of floxuridine (FUdR) for liver metastases from colorectal cancer. Aldrighetti L; Arru M; Ronzoni M; Salvioni M; Villa E; Ferla G Hepatogastroenterology; 2001; 48(41):1302-7. PubMed ID: 11677951 [TBL] [Abstract][Full Text] [Related]
16. A case of large-cell lung carcinoma successfully treated with pembrolizumab but complicated with cholangitis. Ooi R; Tobino K; Sakabe M; Kawabata T; Hiramatsu Y; Sueyasu T; Yoshimine K Respir Med Case Rep; 2020; 31():101197. PubMed ID: 32944497 [TBL] [Abstract][Full Text] [Related]
17. Isolated IgG4-related sclerosing cholangitis misdiagnosed as malignancy in an area with endemic cholangiocarcinoma: a case report. Rungsakulkij N; Sornmayura P; Tannaphai P BMC Surg; 2017 Feb; 17(1):17. PubMed ID: 28202062 [TBL] [Abstract][Full Text] [Related]
18. Case report: Secondary sclerosing cholangitis induced by lapatinib and vinorelbine in a metastasis breast cancer patient. Zhang Z; Xu L; Qin N; Zhang J; Xiang Q; Liu Q; Cheng Y; Bai Y; Liu Q; Liu Y; Duan X; Cui Y Thorac Cancer; 2021 Jun; 12(12):1912-1916. PubMed ID: 33957015 [TBL] [Abstract][Full Text] [Related]
19. A case of sclerosing cholangitis without pancreatic involvement thought to be associated with autoimmunity. Sawai H; Matsubayashi H; Sasaki K; Tanaka M; Kakushima N; Takizawa K; Yamaguchi Y; Ono H Intern Med; 2011; 50(5):433-8. PubMed ID: 21372453 [TBL] [Abstract][Full Text] [Related]
20. Update on Sclerosing Cholangitis in Critically Ill Patients. Kirchner GI; Rümmele P Viszeralmedizin; 2015 Jun; 31(3):178-84. PubMed ID: 26468312 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]